Key facts
- This page summarizes Ivan Tornos's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Feb 2025, 16:09.
Ivan Tornos - 20 Feb 2025 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- ZBH
- Reported as of
- 20 Feb 2025
- Net transaction value
- -$915,207
- SEC form
- 4
- Accepted by SEC
- 24 Feb 2025, 16:09:40 UTC
- Prior SEC filing
- 19 Feb 2025
- Next SEC filing
- 27 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew R. St. Louis, Attorney-in-Fact for Ivan Tornos (power of attorney previously filed)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ivan Tornos filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 24 Feb 2025.
Change
- Previous filing in this sequence was filed on 19 Feb 2025.
- Current net transaction value: -$915,207.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZBH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +15,996
- Change %
- +40%
- Price
- $0.000000
- Shares after
- 56,010
- Date
- 20 Feb 2025
- Ownership
- Direct
ZBH
transaction
Common Stock
Tax liability
- Transaction value
- $915,207
- Shares
- -8,846
- Change %
- -16%
- Price
- $103.46
- Shares after
- 47,164
- Date
- 20 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZBH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -15,996
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 31,991
- Date
- 20 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,996
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
Footnote F2
Each RSU represents a contingent right to receive one share of Company common stock.
Footnote F3
One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027.